Nucleotide sequence of the Mycoplasma genitalium genome, fragments thereof, and uses thereof
Abstract
The present invention provides the nucleotide sequence of the entire genome of Mycoplasma genitalium , SEQ ID NO: 1. The present invention further provides the sequence information stored on computer readable media, and computer-based systems and methods which facilitate its use. In addition to the entire genomic sequence, the present invention identifies protein encoding fragments of the genome, and identifies, by position relative to two (2) genes known to flank the origin of replication, any regulatory elements which modulate the expression of the protein encoding fragments of the Mycoplasma genitalium genome.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated polynucleotide comprising the nucleotide sequence of any one of the fragments of SEQ ID NO: 1 depicted in Tables 1a, 1c and 2, or a degenerate variant thereof.
2 . An isolated polynucleotide complementary to the polynucleotide of claim 1 .
3 . The isolated polynucleotide of claim 1 , wherein said polynucleotide comprises a heterologous nucleic acid sequence.
4 . A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 1 into a vector.
5 . A recombinant vector comprising the isolated polynucleotide of claim 1 .
6 . The recombinant vector of claim 5 , wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.
7 . A recombinant host cell comprising the isolated polynucleotide of claim 1 .
8 . The recombinant host cell of claim 7 , wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.
9 . An isolated polynucleotide comprising a nucleic acid sequence which hybridizes under hybridization conditions comprising hybridization in 5×SSC and 50% formamide at 50° C. and washing in a wash buffer consisting of 0.5× SSC at 65° C., to the complementary strand of any one of the fragments of SEQ ID NO: 1 depicted in Tables 1a, 1c and 2, or a degenerate variant thereof.
10 . An isolated polynucleotide complementary to the polynucleotide of claim 9 .
11 . The isolated polynucleotide of claim 9 , wherein said polynucleotide comprises a heterologous nucleic acid sequence.
12 . A recombinant vector comprising the isolated polynucleotide of claim 9 .
13 . A recombinant host cell comprising the isolated polynucleotide of claim 9 .
14 . An isolated polynucleotide comprising at least 50 contiguous nucleotides of any one of the fragments of SEQ ID NO: 1 depicted in Tables 1a, 1c and 2, or a degenerate variant thereof.
15 . The isolated polynucleotide of claim 14 , wherein said polynucleotide comprises at least 100 contiguous nucleotides of any one of the fragments of SEQ ID NO: 1 depicted in Tables 1a, 1c and 2, or a degenerate variant thereof.
16 . An isolated polynucleotide complementary to the polynucleotide of claim 14 .
17 . The isolated polynucleotide of claim 14 , wherein said polynucleotide comprises a heterologous nucleic acid sequence.
18 . A recombinant vector comprising the isolated polynucleotide of claim 14 .
19 . A recombinant host cell comprising the isolated polynucleotide of claim 14.Join the waitlist — get patent alerts
Track US2003170663A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.